We are joined by Alan Parsa to discuss the most important advances in the use of ultrasound to assess thyroid nodules and the benefits of this technique in determining malignancy risk.
Filmed at the American Diabetes Association (ADA) annual meeting 2019, San Francisco, USA.
1. What are the most important ultrasonographic features for determining the malignancy risk of thyroid nodules? (0:05)
2. How are the major endocrinology societies similar in their classification of malignancy risk of thyroid nodules? (1:21)
3. What are the advantages of the Bethesda System of classification of thyroid nodules? (3:28)
4. What are the benefits of using ultrasound-guided fine needle aspiration for determining malignancy risk? (05:20)
Alan Parsa has no conflicts of interest to declare in relation to this video.
touchENDO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Share this Video
Related Videos In Thyroid Disorders
Kristien Boelaert, ATA 2022: The EGRET study: Long term mortality and cardiometabolic effects of hyperthyroidism treatment
Current evidence indicates cardio‐metabolic effects from antithyroid drugs and other definitive treatment options for hyperthyroidism. The EGRET study aimed to assess the differences in mortality and cardiometabolic outcomes depending on the method of treatment in order to better inform patient‐clinician decision‐making. In this touchENDOCRINOLOGY interview, Prof. Kristien Boelaert (University of Birmingham, Birmingham, United Kingdom) discusses […]
Kristien Boelaert, ATA 2022: Challenges of the long term treatment of hyperthyroidism
Hyperthyroidism, also called overactive thyroid, occurs when your thyroid gland overproduces thyroid hormones. In this touchENDOCRINOLOGY interview, Prof. Kristien Boelaert (University of Birmingham, Birmingham, United Kingdom) discusses the challenges faced in the long term treatment of hyperthyroidism. The abstract entitled: ‘LONG‐TERM MORTALITY AND CARDIOMETABOLIC EFFECTS OF TREATMENT FOR HYPERTHYROIDISM: EGRET STUDY‘ was presented at the American […]
Ferdy van Geest, ETA 2021: Efficacy of T3 analogue Triac for MCT8 deficiency
Dr Ferdy van Geest, (Erasmus Medical Center, Rotterdam, The Netherlands) kindly spoke with us about the results of his study investigating Triac in patients with MCT8. The abstract entitled ‘Long-term efficacy of triiodothyronine analogue Triac in children and adults with monocarboxylate transporter 8 deficiency: an international, real-life cohort study’ (Abstract 82) was given at European […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!